Depakine Enteric, Maagsapresistente Tabletten

Depakine Enteric, Maagsapresistente Tabletten Uses, Dosage, Side Effects, Food Interaction and all others data.

Depakine Enteric, Maagsapresistente Tabletten shows antiepileptic properties in various types of seizures. The exact mechanism of Depakine Enteric, Maagsapresistente Tabletten is not yet established. However it is suggested that its activity is related to increased brain levels of Gama Amino Butyric Acid (GABA).

Trade Name Depakine Enteric, Maagsapresistente Tabletten
Generic Sodium Valproate
Type
Therapeutic Class Primary anti-epileptic drugs
Manufacturer Sanofi
Available Country Netherlands
Last Updated: September 19, 2023 at 7:00 am
Depakine Enteric, Maagsapresistente Tabletten
Depakine Enteric, Maagsapresistente Tabletten

Uses

Depakine Enteric, Maagsapresistente Tabletten is used for -

  • Epilepsy: All types of epilepsy such as Absence seizure, Myoclonic seizure, Tonic-clonic seizure, Atonic, Mixed, simple or generalized, Secondary generalized seizure etc.
  • Mania: For the treatment of manic episodes of bipolar disorders.
  • Other: As an alternative treatment for febrile convulsion & migraine prophylaxis.

Dosage

Depakine Enteric, Maagsapresistente Tabletten dosage

Oral:

Adults:

  • Initial: 600 mg/day in 2 divided doses, preferably after food. Dose may be increased by 200mg/day at 3 days interval to a maximum of 2.5 gm daily in divided doses until control of seizure is achieved.
  • Maintenance dose: Usually 1-2 gm daily (20-30 mg/kg daily).

Children (up to 20 kg):

  • Initial: 20 mg/kg daily in divided doses. Dose may be increased in severe cases with proper monitoring of plasma concentration.

Children (over 20 kg):

  • Initial: 400 mg/ day (irrespective of weight). Dose may be increased by 20-30 mg/ kg if required to achieve control.

Injection:

Depakine Enteric, Maagsapresistente Tabletten is for intravenous use only. Use of Depakine Enteric, Maagsapresistente Tabletten for periods of more than 14 days has not been studied. Patients should be switched to oral valproate products as soon as it is clinically feasible.

Depakine Enteric, Maagsapresistente Tabletten should be administered as a 60 minute infusion (but not more than 20 mg/min) with the same frequency as the oral products, although plasma concentration monitoring and dosage adjustments may be necessary.

In one clinical safety study, approximately 90 patients withepilepsyand with no measurable plasma levels of valproate were given single infusions of Depakine Enteric, Maagsapresistente Tabletten (up to 15 mg/kg and mean dose of 1184 mg) over 5-10 minutes (1.5-3.0 mg/kg/min). Patients generally tolerated the more rapid infusions well. This study was not designed to assess the effectiveness of these regimens.

Side Effects

Gastric irritation, nausea, ataxia & tremor; hyperammonaemia, increased appetite & weight gain; transient hair loss, oedema, thrombocytopenia, and inhibition of platelet aggregation, impaired hepatic function leading rarely to fetal hepatic failure; rashes; sedation; rarely lethargy and confusion and also increased alertness; rarely pancreatitis, leucopenia, pancytopenia, red cell hypoplasia, fibrinogen reduction; irregular periods, amenorrhoea, gynaecomastia, toxic epidermal necrolysis, hearing loss, Fancoli's syndrome, dementia, Steven's-Johnson syndrome, and vasculitis have also been reported.

Precaution

Liver function should be monitored before therapy and during first six months, especially in those patients who seem most at risk. Blood tests are recommended before surgery. Renal impaired patients, pregnant and brest feeding mother should be specially cared. Valproate is eliminated mainly through the kidney, partly in the form of ketone bodies which may lead to false statement in urine ketone test. Sudden withdrawal of therapy should be avoided

Interaction

Depakine Enteric, Maagsapresistente Tabletten is a non specific inhibitor of drug metabolism. Phenobarbital, Phenytoin, Warfarin, Aspirin etc. interacts with Depakine Enteric, Maagsapresistente Tabletten.

Pregnancy & Breastfeeding use

Depakine Enteric, Maagsapresistente Tabletten crosses the placenta in humans which may lead to neural tube defects such as anencephaly and spina bifida if exposed in the first trimester. Depakine Enteric, Maagsapresistente Tabletten may excrete in breast milk. So treatment with Depakine Enteric, Maagsapresistente Tabletten may cause harm to new born baby.

Contraindication

Depakine Enteric, Maagsapresistente Tabletten is contra-indicated in patients with known hypersensitivity of Depakine Enteric, Maagsapresistente Tabletten, personal or family history of severe active liver disease, hepatic dysfunction, porphyria and known urea cycle disorder.

Storage Condition

Syrup: Store below 30° C, protected from light.

Tablet: Store below 30° C, protected from light. Keep all medicines out of the reach of children.

Innovators Monograph

You find simplified version here Depakine Enteric, Maagsapresistente Tabletten

FAQ

What is Depakine Enteric, Maagsapresistente Tabletten used for?

Depakine Enteric, Maagsapresistente Tabletten used to treat epilepsy and bipolar disorder. It's occasionally used to prevent migraine headaches. This medicine is only available on prescription.

How safe is Depakine Enteric, Maagsapresistente Tabletten?

Many people can take Depakine Enteric, Maagsapresistente Tabletten safely for many months or years. However, there are potential side effects that can happen over a long time. Long-term treatment with Depakine Enteric, Maagsapresistente Tabletten can cause osteoporosis and osteopenia.

How long does it take for sodium valproate to work?

Depakine Enteric, Maagsapresistente Tabletten may take several days to show an initial effect and in some cases may take from two to six weeks for maximum effect. Treatment is started with low doses and may be increased over a couple of weeks according to your child's response.

What are the common side effects of Depakine Enteric, Maagsapresistente Tabletten?

The common side effects of Depakine Enteric, Maagsapresistente Tabletten are include:

  • stomach pain, feeling or being sick
  • diarrhoea
  • dry or sore mouth, or swollen gums
  • shakes (tremors) in a part of your body, or unusual eye movements
  • feeling tired or sleepy
  • headache
  • weight gain
  • thinning hair, or changes to the colour or texture of your hair
  • irregular or delayed periods

How to take Depakine Enteric, Maagsapresistente Tabletten?

Depakine Enteric, Maagsapresistente Tabletten comes as slow release (prolonged or sustained release) tablets, capsules and granules, gastro-resistant tablets, crushable tablets, and as a liquid.
Slow release medicine passes into your body gradually.

When is the best time to take Depakine Enteric, Maagsapresistente Tabletten?

You can take Depakine Enteric, Maagsapresistente Tabletten with or without food, but it's best to stick to the same way each time. Do not take it with food some days and without food on other days.

How often can I take Depakine Enteric, Maagsapresistente Tabletten?

If you're taking Depakine Enteric, Maagsapresistente Tabletten once a day, you can choose a time that suits you. Just try to keep to the same time every day.
If you're taking Depakine Enteric, Maagsapresistente Tabletten twice a day, try to leave a gap of 10 to 12 hours between doses. For example you could take your first dose in the morning (between 7am and 8am) and your second dose in the evening (between 7pm and 8pm).

Is Depakine Enteric, Maagsapresistente Tabletten safe during pregnancy?

Depakine Enteric, Maagsapresistente Tabletten is not recommended in pregnancy, as it can cause birth defects and problems with your baby's learning and behaviour.
If there's a chance you could become pregnant while taking this medicine, your doctor will put you on Prevent, the Depakine Enteric, Maagsapresistente Tabletten prevention programme.

Is Depakine Enteric, Maagsapresistente Tabletten safe during breastfeeding?

If your doctor or health visitor says your baby is healthy you can take Depakine Enteric, Maagsapresistente Tabletten while breastfeeding.
Depakine Enteric, Maagsapresistente Tabletten passes into breast milk in small amounts but it's unlikely to harm your baby so you can continue breastfeeding if your doctor says you need to take it.

How long will I take Depakine Enteric, Maagsapresistente Tabletten?

Once your condition is under control, you'll usually need to keep taking Depakine Enteric, Maagsapresistente Tabletten for many years.

Is Depakine Enteric, Maagsapresistente Tabletten safe to take it for a long time?

Many people can take Depakine Enteric, Maagsapresistente Tabletten safely for many months or years.
However, there are potential side effects that can happen over a long time. Long-term treatment with Depakine Enteric, Maagsapresistente Tabletten can cause osteoporosis and osteopenia.

What will happen when I come off Depakine Enteric, Maagsapresistente Tabletten?

Do not stop taking Depakine Enteric, Maagsapresistente Tabletten suddenly, unless your doctor tells you to.
You're unlikely to get any extra symptoms when you stop taking this medicine. However, if you're taking Depakine Enteric, Maagsapresistente Tabletten for epilepsy, it's possible that you'll get seizures again once you stop taking it. You can prevent these withdrawal seizures by reducing your dose of Depakine Enteric, Maagsapresistente Tabletten gradually.

Can I drink alcohol with Depakine Enteric, Maagsapresistente Tabletten?

Drinking alcohol while taking Depakine Enteric, Maagsapresistente Tabletten may make you feel sleepy or tired. It's best to stop drinking alcohol during the first few days, until you see how the medicine affects you.

Will Depakine Enteric, Maagsapresistente Tabletten affect my fertility?

Depakine Enteric, Maagsapresistente Tabletten can reduce fertility in both men and women. Once you stop taking this medicine, your fertility will return.In men Depakine Enteric, Maagsapresistente Tabletten has been reported to cause infertility.

Will Depakine Enteric, Maagsapresistente Tabletten affect my contraception?

Depakine Enteric, Maagsapresistente Tabletten does not affect any type of contraception, including the combined pill and emergency contraception.If there's a chance you could become pregnant while taking Depakine Enteric, Maagsapresistente Tabletten you must use contraception. Your doctor will put you on Prevent, the valproate pregnancy prevention programme.

Can I drive after taking Depakine Enteric, Maagsapresistente Tabletten?

You may feel sleepy, tired or dizzy when you first start taking Depakine Enteric, Maagsapresistente Tabletten. This may also happen if your dose has increased. If you're affected, do not drive or ride a bike until you feel more alert.

Can I take too much dose of Depakine Enteric, Maagsapresistente Tabletten?

Taking too much Depakine Enteric, Maagsapresistente Tabletten can lead to symptoms such as: feeling or being sick, headaches or feeling dizzy,muscle weakness.

What happen If I missed Depakine Enteric, Maagsapresistente Tabletten?

If you've missed a dose, what you do next depends on whether you usually take your medicine once or twice a day. If you take Depakine Enteric, Maagsapresistente Tabletten once a day ,take the forgotten dose as soon as you remember unless it's within a few hours of the next dose.

Who should not take Depakine Enteric, Maagsapresistente Tabletten?

You should not use Depakine Enteric, Maagsapresistente Tabletten if you are allergic to it.


*** Taking medicines without doctor's advice can cause long-term problems.
Share